middle.news
Island Pharmaceuticals Completes Phase 2b Dosing in Dengue Treatment Trial
8:39am on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Completes Phase 2b Dosing in Dengue Treatment Trial
8:39am on Monday 2nd of June, 2025 AEST
Key Points
Completed dosing of 10 subjects in Phase 2b therapeutic arm
Phase 2b follows positive Phase 2a prophylactic results and safety review
Primary endpoint: reduction of dengue virus load (viremia)
High-level results anticipated by April 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE